Cargando…
The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials
Docosahexaenoic acid (DHA), also known as omega-3 (n-3) polyunsaturated fatty acid (PUFA), is a natural compound that has demonstrated pharmacological activity against several malignant neoplasms. Available cancer treatments cause side effects, affect healthy cells, reduce the quality of life of pat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141663/ https://www.ncbi.nlm.nih.gov/pubmed/37111226 http://dx.doi.org/10.3390/nu15082006 |
_version_ | 1785033434088865792 |
---|---|
author | de Freitas Rodrigues, Jaqueline Philippsen, Hellen Kempfer Dolabela, Maria Fani Nagamachi, Cleusa Yoshiko Pieczarka, Julio Cesar |
author_facet | de Freitas Rodrigues, Jaqueline Philippsen, Hellen Kempfer Dolabela, Maria Fani Nagamachi, Cleusa Yoshiko Pieczarka, Julio Cesar |
author_sort | de Freitas Rodrigues, Jaqueline |
collection | PubMed |
description | Docosahexaenoic acid (DHA), also known as omega-3 (n-3) polyunsaturated fatty acid (PUFA), is a natural compound that has demonstrated pharmacological activity against several malignant neoplasms. Available cancer treatments cause side effects, affect healthy cells, reduce the quality of life of patients and may cause resistance to antineoplastics. For these reasons, the search for new therapies is continuous. This narrative review aimed to compile information on in vitro experiments that study the cytotoxic effect of DHA or molecules derived from DHA in tumor and nontumor cells. This was performed to highlight the potential of DHA as a strategy for cancer therapy and to gather information, which will help researchers plan experimental designs and develop research to discover effective therapies against cancer. In addition, studies were presented that demonstrate the dose of DHA that can treat patients with cancer. Thus, a search was conducted for articles on the SCOPUS and Web of Science platforms, published until 2022, that analyzed the action of DHA against breast, lung, colorectal, prostate, stomach and liver cancers. Cytotoxic effects were observed in tumor and nontumor cell lines, and these results varied with the type of cell line studied, drug concentration, incubation time and treatment combination, i.e., with DHA alone, combined with other drugs and with molecules derived from DHA. In patients with cancer, in all analyzed studies, DHA intake was associated with eicosapentaenoic acid (EPA) and/or proteins to aid chemotherapy, and with this procedure, tumor reduction, chemotherapy tolerance and muscle mass gain were obtained. This work contributes to the community by demonstrating the possible applicability of DHA in the pharmaceutical area of oncological therapies. |
format | Online Article Text |
id | pubmed-10141663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101416632023-04-29 The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials de Freitas Rodrigues, Jaqueline Philippsen, Hellen Kempfer Dolabela, Maria Fani Nagamachi, Cleusa Yoshiko Pieczarka, Julio Cesar Nutrients Review Docosahexaenoic acid (DHA), also known as omega-3 (n-3) polyunsaturated fatty acid (PUFA), is a natural compound that has demonstrated pharmacological activity against several malignant neoplasms. Available cancer treatments cause side effects, affect healthy cells, reduce the quality of life of patients and may cause resistance to antineoplastics. For these reasons, the search for new therapies is continuous. This narrative review aimed to compile information on in vitro experiments that study the cytotoxic effect of DHA or molecules derived from DHA in tumor and nontumor cells. This was performed to highlight the potential of DHA as a strategy for cancer therapy and to gather information, which will help researchers plan experimental designs and develop research to discover effective therapies against cancer. In addition, studies were presented that demonstrate the dose of DHA that can treat patients with cancer. Thus, a search was conducted for articles on the SCOPUS and Web of Science platforms, published until 2022, that analyzed the action of DHA against breast, lung, colorectal, prostate, stomach and liver cancers. Cytotoxic effects were observed in tumor and nontumor cell lines, and these results varied with the type of cell line studied, drug concentration, incubation time and treatment combination, i.e., with DHA alone, combined with other drugs and with molecules derived from DHA. In patients with cancer, in all analyzed studies, DHA intake was associated with eicosapentaenoic acid (EPA) and/or proteins to aid chemotherapy, and with this procedure, tumor reduction, chemotherapy tolerance and muscle mass gain were obtained. This work contributes to the community by demonstrating the possible applicability of DHA in the pharmaceutical area of oncological therapies. MDPI 2023-04-21 /pmc/articles/PMC10141663/ /pubmed/37111226 http://dx.doi.org/10.3390/nu15082006 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review de Freitas Rodrigues, Jaqueline Philippsen, Hellen Kempfer Dolabela, Maria Fani Nagamachi, Cleusa Yoshiko Pieczarka, Julio Cesar The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials |
title | The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials |
title_full | The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials |
title_fullStr | The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials |
title_full_unstemmed | The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials |
title_short | The Potential of DHA as Cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials |
title_sort | potential of dha as cancer therapy strategies: a narrative review of in vitro cytotoxicity trials |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141663/ https://www.ncbi.nlm.nih.gov/pubmed/37111226 http://dx.doi.org/10.3390/nu15082006 |
work_keys_str_mv | AT defreitasrodriguesjaqueline thepotentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT philippsenhellenkempfer thepotentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT dolabelamariafani thepotentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT nagamachicleusayoshiko thepotentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT pieczarkajuliocesar thepotentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT defreitasrodriguesjaqueline potentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT philippsenhellenkempfer potentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT dolabelamariafani potentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT nagamachicleusayoshiko potentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials AT pieczarkajuliocesar potentialofdhaascancertherapystrategiesanarrativereviewofinvitrocytotoxicitytrials |